The power crisis brewing in China may throw the Indian pharma market off gear if the situation continues for a few more months, feel sources in the local industry. Indian players roughly import 66-70 per cent of their bulk drug requirements from China.
Already, prices of active pharmaceutical ingredients (APIS), raw materials to make drugs, have gone up significantly and there are delays in shipments to India.
Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA), the umbrella organisation of big pharma players in India, said prices of APIs have started going up. “Prices of Penicillin-G from China have gone up from $14 per unit to $26 in just one month, he said, adding that India does not have large capacities to make such fermentation-based APIs.
IPA members account for 60 per cent of the domestic market and about 80 per cent of India's exports of pharmaceutical products.
Jain added that supplies are coming, but there are delays in shipments. “Apart from the power shortage problem plaguing the industry in China, there are also issues with shipping.
Diese Geschichte stammt aus der October 28, 2021-Ausgabe von Business Standard.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent ? Anmelden
Diese Geschichte stammt aus der October 28, 2021-Ausgabe von Business Standard.
Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.
Bereits Abonnent? Anmelden
Bandhan Bank Q4 profit falls 94% to ₹54.6 crore
Bandhan Bank on Friday reported a 93.24 per cent drop in its net profit to ₹54.6 crore in the March quarter (Q4FY24) compared to a profit of ₹808.3 crore in the corresponding quarter of the previous financial year.
UN ups India's CY24 growth forecast
The United Nations (UN) has revised upwards India's growth forecast for 2024 by 70 basis points to 6.9 per cent, from 6.2 per cent estimated in January this year, driven by robust public investment and resilient private consumption.
RBI flags concerns over functioning of debt recast firms
Meeting with ARCS part of supervisory engagements
Adani Ports & SEZ shares stable after Norges Bank exit
A day after Norway's Norges Bank decided to sell its shares in Adani Ports & Special Economic Zone, the company's shares closed stable at ₹1,336 a share on Friday.
Trent, Bharat Electronics in Nifty 50 contention
Tata group retailer Trent and state-owned Bharat Electronics Ltd (BEL) are seen as likely contenders to the benchmark Nifty 50 index during the next rebalancing exercise in September.
M&M stock races ahead on strong Q4 results, healthy outlook
Mahindra (M&M) reported very strong results for the January-March quarter of the last financial year (Q4FY24), beating consensus comfortably.
Silver outpaces gold as buying gains momentum
Gold's record-setting rally may have captured the headlines this year, but it's silver that's running harder and faster as the less glamorous metal benefits from robust financial and industrial demand.
Go Digit IPO booked 9.6x on last day, QIBS bet big
The ₹2,615 crore initial public offering (IPO) of the Fairfaxbacked Go Digit General Insurance closed on Friday, with the issue getting subscribed over 9.6 times.
Bajaj MF adds to variety in multi-asset space
Takes the dividend yield route to stand out in emerging hybrid category
Heavyweights lift Sensex, Nifty
Equity benchmarks Sensex and Nifty closed higher for a second straight day on Friday as buying in index majors M&M, Reliance Industries, and ITC helped the indices rebound from early lows.
